UNASSIGNED: Solid @entity5 are much more common than @entity1583 . Although severe and prolonged @entity1398 is uncommon, several factors increase the risk of @entity281 in @entity1 with @entity5 , and the presence of multiple risk factors in the same @entity1 is not uncommon. These include obstruction (most often caused by progression of the @entity5 ), disruption of natural anatomic barriers such as the skin and mucosal surfaces, and treatment-related factors such as chemotherapy, radiation, diagnostic and/or therapeutic surgical procedures, and the increasing use of medical devices such as various catheters, stents, and prostheses. Common sites of @entity281 include the skin and skin structures (including surgical site @entity281 ), the bloodstream (including @entity281 associated with central venous catheters), the lungs, the hepato-biliary and intestinal tracts, and the urinary tract, and include distinct clinical syndromes such as @entity55 , @entity3551 , and @entity24386 . The epidemiology of most of these @entity281 is changing with resistant organisms [ @entity794 , @entity796 , extended spectrum beta-lactamase (ESBL)-producing organisms] being isolated more often than in the past. Polymicrobial @entity281 now predominate when deep tissue sites are involved. Conservative management of most of these @entity281 (antibiotics, fluid and electrolyte replacement, bowel rest when needed) is generally effective, with surgical intervention being reserved for the @entity733 , or to deal with complications such as @entity548 . Infected prostheses often need to be removed. Reactivation of certain @entity1800 ( @entity97 , @entity3531 , and occasionally @entity2834 ) has become an important issue, and screening, prevention and treatment strategies are being developed. Infection prevention, @entity281 control, and antimicrobial stewardship are important strategies in the overall management of @entity281 in @entity1 with @entity5 . Occasionally, @entity281 mimic @entity5 and cause diagnostic and therapeutic challenges.

Infections in XXXX @entity1 with @entity5 : A Review.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity3551 :: ('MESH:C536483', 'Disease') :: ['obstructive uropathy'] @entity97 :: ('10407', 'Species') :: ['HBV'] @entity24386 :: ('MESH:D044504', 'Disease') :: ['neutropenic enterocolitis'] @entity796 :: ('287', 'Species') :: ['Pseudomonas aeruginosa'] @entity548 :: ('MESH:D006470', 'Disease') :: ['intestinal obstruction or hemorrhage'] @entity55 :: ('MESH:D011014', 'Disease') :: ['post-obstructive pneumonia'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'solid tumors', 'tumors'] @entity3531 :: ('11096', 'Species') :: ['HCV'] @entity794 :: ('1280', 'Species') :: ['MRSA'] @entity281 :: ('MESH:D007239', 'Disease') :: ['infection', 'infections'] @entity1398 :: ('MESH:D009503', 'Disease') :: ['neutropenia'] @entity1800 :: ('MESH:D014777', 'Disease') :: ['viral infections'] @entity733 :: ('MESH:D000038', 'Disease') :: ['drainage of deep abscesses'] @entity1583 :: ('MESH:D019337', 'Disease') :: ['hematologic malignancies'] @entity2834 :: ('12305', 'Species') :: ['CMV']
@entity5 :: (MESH:D009369,Disease) :: ['Cancer']
